angiotensin ii, des-phe(8)- has been researched along with tetraethylammonium in 1 studies
Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (tetraethylammonium) | Trials (tetraethylammonium) | Recent Studies (post-2010) (tetraethylammonium) |
---|---|---|---|---|---|
1,533 | 21 | 995 | 3,877 | 10 | 298 |
Protein | Taxonomy | angiotensin ii, des-phe(8)- (IC50) | tetraethylammonium (IC50) |
---|---|---|---|
Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.54 | |
Solute carrier family 22 member 2 | Mus musculus (house mouse) | 3.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Carvalho, MH; de Cássia Tostes Passaglia, R; dos Santos, R; Fortes, ZB; Nigro, D; Oliveira, MA; Rastelli, VM | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and tetraethylammonium
Article | Year |
---|---|
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.
Topics: Angiotensin I; Animals; Animals, Newborn; Blood Glucose; Bradykinin; Diabetes Mellitus, Type 2; Drug Interactions; Gene Expression; Hypoglycemic Agents; Immunohistochemistry; Indomethacin; Insulin; Male; NG-Nitroarginine Methyl Ester; Ouabain; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bradykinin; Reverse Transcriptase Polymerase Chain Reaction; Streptozocin; Tetraethylammonium; Vasodilation | 2007 |